Mucosomes as next-generation drug carriers for treating mucus-resident bacterial infections and biofilms
Abstract Deaths connected to bacterial infections are expected to outnumber those caused by cancer by 2050. Multiple advantages, including enhanced efficacy of the treatment, characterize the use of nanocarriers to deliver antibiotics. This work explores the use of mucosomes – intrinsically glycosyl...
Saved in:
| Main Authors: | Giuseppe Guagliano, Emanuela Peluso, Cosmin Stefan Butnarasu, Elisa Restivo, Lorenzo Sardelli, Enrica Frasca, Paola Petrini, Nicola Tirelli, Stefania Sganga, Livia Visai, Sonja Visentin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-10496-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Indicators of cytological composition of the nasal mucus in children with acute respiratory viral infection
by: O. I. Smiyan, et al.
Published: (2016-12-01) -
Gastric‐type duodenal neoplasms with rapid growth: A report of two cases
by: Rikimaru Sawada, et al.
Published: (2023-04-01) -
Using MUC2 mucin producing tumorigenic human goblet-like cells to uncover functional properties of the mucus barrier
by: Hayley Gorman, et al.
Published: (2025-12-01) -
The barrier and beyond: Roles of intestinal mucus and mucin-type O-glycosylation in resistance and tolerance defense strategies guiding host-microbe symbiosis
by: Kirk Bergstrom, et al.
Published: (2022-12-01) -
Synthesis New Liquid Selective Electrodes of Ciprofloxacin Hydrochloride for Determination Ciprofloxacin in Pure form and Pharmaceuticals Preparation.
by: Baghdad Science Journal
Published: (2017-12-01)